Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence. Go to Publication You Might Also Like Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. September 5, 2016 Health seeking behaviour among tuberculosis patients in rural South Africa. April 2, 2002 Resistance to second-line drugs in multidrug-resistant tuberculosis. February 23, 2013 Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017 A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective. November 15, 2017
Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. September 5, 2016
Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective. November 15, 2017